Immunovia AB (publ), a diagnostic company, develops and commercializes blood-based diagnostics for cancer in Sweden and internationally. It offers IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. The company was incorporated in 2007 and is headquartered in Lund, Sweden.
Stock data | 2024 | Change |
---|---|---|
Price | $0.09325562031640298 | N/A |
Market Cap | $4.22M | N/A |
Shares Outstanding | 45.29M | N/A |
Employees | 25.00 | N/A |